Wegovy Wearing Off: Why It Happens and What It Means for Your Treatment

Why does Wegovy seem to wear off before the next injection is due?

Semaglutide has a half-life of roughly one week, which is why it is dosed weekly. But half-life is an average, and individual responses vary. After each injection, the medicine's concentration in your bloodstream rises over a day or two, then declines. At lower doses, the trough (the level just before the next injection) may fall far enough that appetite suppression becomes noticeably weaker towards the end of the week. Many people find this smooths out as the dose increases, because the trough level rises too.

There is a distinction worth making here. End-of-week hunger returning is not the same as the medicine failing; it reflects normal pharmacokinetics. What matters is whether the effect across the whole week is broadly sufficient, and whether your weight is still moving in the direction your prescriber expects. If the end-of-week dip is making the last two days consistently difficult, that is worth documenting and raising at your next review rather than adjusting anything yourself. The end-of-week effect and its causes are covered in more detail in a related piece, which may be useful reading alongside this one.

The NHS medicines page for semaglutide is a useful starting point for understanding how the medicine works and what to expect from each phase of treatment.

Is a weight-loss plateau the same as the medicine wearing off?

Not quite. A plateau (where weight loss slows or stops despite continuing treatment) is well documented in clinical trials. It tends to appear after several months at a maintenance dose, often around the six- to twelve-month mark. The body adapts: resting metabolism adjusts, and the medicine's suppression of appetite may feel less dramatic simply because appetite has already been reduced for a sustained period. This is a different situation from feeling hungry again three days after an injection.

In the STEP 1 trial, published in the New England Journal of Medicine, average weight loss on semaglutide 2.4mg over 68 weeks was around 15%. Most of that loss happened in the first six months, with the curve flattening later. That flattening was not because the medicine stopped working; it reflects the point at which energy intake and output reach a new equilibrium. If you are on a dose below the 2.4mg maintenance level and weight loss has stalled, your prescriber may consider titrating upward. The longer-term pattern of how the effect changes is worth understanding separately from the weekly rhythm.

One thing our prescribers hear fairly often: people assume a plateau means they need to stop, when in many cases they are simply at the point where active loss transitions to maintenance. A clinical review can clarify which situation applies to you.

Could something else be blunting the effect?

Yes, and it is worth running through the practical checklist before assuming the medicine itself is the problem.

Storage matters more than people realise. Wegovy pens must be kept refrigerated at 2–8°C; exposure to higher temperatures (a car glove box on a warm day, a bathroom cabinet in summer) can degrade the medicine. Always check the Patient Information Leaflet for the exact guidance on room-temperature windows, as these are specific to the product and it would not be appropriate to paraphrase them here.

Injection technique also plays a role. Injecting too shallowly, into scar tissue from a repeatedly used site, or not completing the injection fully can all reduce the dose absorbed. Rotating between the abdomen, thigh, and upper arm is recommended for this reason. A small practical point: some people find it easiest to set a weekly reminder for the same day each week, which removes any creeping delay that shortens the effective window.

Finally, if you take oral medicines alongside Wegovy (including hormonal contraceptives) it is worth knowing that semaglutide slows gastric emptying, which can in theory affect absorption of other medicines. This is a conversation for your prescriber or GP rather than something to act on unilaterally. If you want to understand when semaglutide wears off and what drives that timing, that is covered in more depth elsewhere alongside the pharmacokinetics. Whether semaglutide's effect dips within the week is explored in more depth elsewhere if you want the pharmacokinetics broken down further.

When should you speak to a prescriber about this?

There is no hard rule, but a few situations definitely call for a clinical conversation rather than waiting.

If hunger has returned sharply and consistently across most of the week (not just the day before your next injection) that is worth raising. The same applies if your weight has not moved for six to eight weeks at the current dose, or if side effects that initially settled have returned more intensely. A prescriber can look at where you are in the titration schedule, review whether a dose increase is clinically appropriate, and check that nothing in your health picture has changed.

It is also worth remembering that Wegovy is a prescription-only medicine, which means any change to how you use it (the timing, the dose, the frequency) requires a prescriber's sign-off, not a personal experiment. The broader question of whether Wegovy's effects diminish over time addresses what happens if you stop the medicine, which is a separate but related concern.

If cost is a factor in how you are thinking about your treatment, a look at our Wegovy price comparison for the UK may help you understand what private treatment typically involves. And if you want to understand how semaglutide fits into the wider picture of weight-management options, our weight-loss treatment overview covers the licensed medicines available through a private regulated pharmacy.

A prescriber review is the right next step if you are concerned. You can start that process with a free consultation, reviewed the same day by a named GPhC-registered prescriber.